Re: Brexit
To expand on what jon has posted above...
https://www.supplychaindive.com/news...ration/436496/
Quote:
Merck & Co.'s 2015/2016 Corporate Responsibility Report reveals the company's manufacturing initiatives for two simple mandates: reduce costs and increase capacity. Optimizing supply chain management to better match production with buyer demand promises to do both simultaneously.
"Our manufacturing division has undertaken an ambitious program to reduce the cost of production by reducing underutilized capacity, increasing efficiency through Lean and Six Sigma projects at manufacturing sites, reducing procurement spending, and improving supply performance, including on-time deliveries and reduction of supply shortages," the company wrote in the report.
But the mandate is easier said than done. In addition to Merck's various planning hubs and private manufacturing facility, the company also operates 148 external manufacturing plants and produces 10,300 different product size finishes. In addition, each facility likely communicates with a number of pharmaceutical ingredient suppliers, packaging companies and distributors. The scale of the company's operations alone complicates any forecast.
|
https://www.pharmalogisticsiq.com/re...-supply-chains
Quote:
In the space of 6 months, the level of EU businesses that expect to move some of their supply chain out of the UK due to Brexit jumped up by 19% to 63% of the practitioners surveyed
|
__________________
There is always light.
If only we’re brave enough to see it.
If only we’re brave enough to be it.
If my post is in bold and this colour, it's a Moderator Request.
Last edited by Hugh; 12-06-2019 at 21:59.
|